These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37111714)

  • 21. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.
    Mei L; Xie Y; Huang Y; Wang B; Chen J; Quan G; Pan X; Liu H; Wang L; Liu X; Wu C
    Acta Biomater; 2018 Feb; 67():99-110. PubMed ID: 29225151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel 3-month drug releasing risperidone microspheres.
    Yerragunta B; Jogala S; Chinnala KM; Aukunuru J
    J Pharm Bioallied Sci; 2015; 7(1):37-44. PubMed ID: 25709335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
    Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
    Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment.
    Chen X; Chen J; Li B; Yang X; Zeng R; Liu Y; Li T; Ho RJY; Shao J
    J Colloid Interface Sci; 2017 Mar; 490():542-552. PubMed ID: 27923139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
    Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
    J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Drug Physicochemical Properties on In-Situ Forming Implant Polymer Degradation and Drug Release Kinetics.
    Joiner JB; Prasher A; Young IC; Kim J; Shrivastava R; Maturavongsadit P; Benhabbour SR
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism.
    Wang L; Wang A; Zhao X; Liu X; Wang D; Sun F; Li Y
    Int J Pharm; 2012 May; 427(2):284-92. PubMed ID: 22387369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ subcutaneously injectable thermosensitive PEG-PLGA diblock and PLGA-PEG-PLGA triblock copolymer composite as sustained delivery of bispecific anti-CD3 scFv T-cell/anti-EGFR Fab Engager (BiTEE).
    Wei PS; Chen YJ; Lin SY; Chuang KH; Sheu MT; Ho HO
    Biomaterials; 2021 Nov; 278():121166. PubMed ID: 34634663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Situ Forming Injectable Thermoresponsive Hydrogels for Controlled Delivery of Biomacromolecules.
    Dutta K; Das R; Ling J; Monibas RM; Carballo-Jane E; Kekec A; Feng DD; Lin S; Mu J; Saklatvala R; Thayumanavan S; Liang Y
    ACS Omega; 2020 Jul; 5(28):17531-17542. PubMed ID: 32715238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLGA-PEG-PLGA tri-block copolymers as in situ gel-forming peptide delivery system: effect of formulation properties on peptide release.
    Ghahremankhani AA; Dorkoosh F; Dinarvand R
    Pharm Dev Technol; 2008; 13(1):49-55. PubMed ID: 18300099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.
    Shen J; Choi S; Qu W; Wang Y; Burgess DJ
    J Control Release; 2015 Nov; 218():2-12. PubMed ID: 26423236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis.
    Daugherty AL; Rangell LK; Eckert R; Zavala-Solorio J; Peale F; Mrsny RJ
    Eur J Pharm Biopharm; 2011 Jun; 78(2):289-97. PubMed ID: 21426936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam.
    Christian R; Thakkar V; Patel T; Gohel M; Baldaniya L; Shah P; Pandya T; Gandhi T
    Curr Drug Deliv; 2019; 16(1):66-78. PubMed ID: 30264681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracranial In Situ Thermosensitive Hydrogel Delivery of Temozolomide Accomplished by PLGA-PEG-PLGA Triblock Copolymer Blending for GBM Treatment.
    Gu W; Fan R; Quan J; Cheng Y; Wang S; Zhang H; Zheng A; Song S
    Polymers (Basel); 2022 Aug; 14(16):. PubMed ID: 36015626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A protocol for assay of poly(lactide-co-glycolide) in clinical products.
    Garner J; Skidmore S; Park H; Park K; Choi S; Wang Y
    Int J Pharm; 2015 Nov; 495(1):87-92. PubMed ID: 26319639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of depot PLGA-based
    Gomaa E; Eissa NG; Ibrahim TM; El-Bassossy HM; El-Nahas HM; Ayoub MM
    Saudi Pharm J; 2023 Apr; 31(4):499-509. PubMed ID: 37063437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA.
    Khodaverdi E; Tekie FS; Mohajeri SA; Ganji F; Zohuri G; Hadizadeh F
    AAPS PharmSciTech; 2012 Jun; 13(2):590-600. PubMed ID: 22528547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability.
    Schoenhammer K; Petersen H; Guethlein F; Goepferich A
    Int J Pharm; 2009 Apr; 371(1-2):33-9. PubMed ID: 19135512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermo-sensitive hydrogel PLGA-PEG-PLGA as a vaccine delivery system for intramuscular immunization.
    Wang X; Zhang Y; Xue W; Wang H; Qiu X; Liu Z
    J Biomater Appl; 2017 Jan; 31(6):923-932. PubMed ID: 27888253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections:
    Elhabal SF; Ghaffar SA; Hager R; Elzohairy NA; Khalifa MM; Mohie PM; Gad RA; Omar NN; Elkomy MH; Khasawneh MA; Abdelaal N
    Int J Pharm X; 2023 Dec; 5():100174. PubMed ID: 36908304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.